Hints and tips:
...I think a lot of people were anticipating a V-shaped recovery . . . People are now waking up the realisation that volatility is going to be normal going forward.”...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Additional reporting by Andrew Edgecliffe-Johnson in New York...
...Mr Johnson argued that the home improvement trend had room to run....
...on Thursday after the ride-hailing company promised profitability in the final quarter of this year, officials in London and Washington told the FT that Donald Trump vented in “apoplectic” fury at Boris Johnson...
...“Fees are infinitesimally small because index funds have spawned competition hugely beneficial to the investor,” says Ben Johnson of Morningstar, the fund-ratings group....
...strong the feeling against Netflix at Cannes, there will be an opportunity to watch one film that will be distributed by the streamer: Wounds by Babak Anvari, a thriller that stars Armie Hammer and Dakota Johnson...
...“It’s not like the standard V-shaped recession in emerging markets, such as in Indonesia in 1998 where it’s only a year and a half of real economic hardship,” he said....
...The group behind the Les Paul, Flying V and Epiphone brands filed for Chapter 11 bankruptcy protection in May, overwhelmed by the debt it took on to fund an ill-fated diversification into headphones and...
...The last time Pfizer sold its consumer health division, in 2006, Johnson & Johnson paid $16.6bn, just over four times sales....
...But it subsequently took on a new portfolio when it acquired Wyeth in 2010....
...A 2009 Supreme Court case involving prescription drug labels, Wyeth v Levine, greenlighted state laws that are stricter than federal laws....
...Other big US drugmakers, including Johnson & Johnson, Merck and Amgen, would benefit in the same way from a so-called “inversion” with an overseas company and will be left at a disadvantage to Pfizer...
.... …………………………………………………………………………………………………………… Ben Hall, world news editor, picks: • Isis Inc: how oil fuels jihadi terrorists by Erika Solomon, Guy Chazan and Sam Jones• Why China’s ‘migrant miracle’ is...
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
...Put together, the pair would rival Johnson & Johnson as industry number one. AstraZeneca has been struggling in recent years as blockbuster drugs have lost market exclusivity....
...& Johnson as the world’s biggest drugmaker....
...When Johnson & Johnson wanted to boost prescriptions of Natrecor, a heart medicine, it channelled more than $100,000 through a subsidiary company to a sympathetic nurse....
...the Analysts, Martoma claimed to have “black edge” —illicit, nonpublic information… The Analysts exchanged a number of emails and instant messages with Cohen about whether Martoma’s advice on Elan and Wyeth...
...Two foreign companies, Nestlé’s Wyeth Nutrition unit and Meiji Dairies of Japan, were also included in the NDRC’s probe but were not penalised....
...What caused a stir was the designer’s low V-neck mermaid gown with bandeau accent, modified from her autumn show....
...Pfizer inherited brands including Anadin, Preparation H and ChapStick as part of its purchase of Wyeth in 2009, just three years after selling its own CH business to Johnson & Johnson....
...Hermès also worked with the Four Seasons George V hotel in Paris to create a hand-built Rolls-Royce Phantom, custom-made to the hotel’s specifications....
...Johnson & Johnson has already agreed a similar settlement for bribery linked to pharmaceutical sales, and several have been concluded with medical device companies in recent months....
International Edition